New data on CASODEX (bicalutamide) Tablets released here at the 34th Annual Meeting of the American Society of Clinical Oncology offer additional evidence of the medicationÃs positive clinical benefits, both as monotherapy and in combination with a luteinizing hormone-releasing hormone analogue (LHRH-A), in the treatment of advanced prostate cancer.